Table 1

DMT attributes and levels

AttributesLevelsDescription
Preventing relapse2Presenting a relapse every 2 years
Presenting a relapse every 5 years
Preventing disease progression2Preventing the disease from getting worse/progressing for 2 years
Preventing the disease from getting worse/progressing for 5 years
Side effect risk2Rare but severe, life-threatening side effects (including PML)
Frequent but mild/moderate side effects
Route of administration3Oral
Subcutaneous–intramuscular
Intravenous
Frequency of administration4Daily
Every 2 days—weekly
Monthly
Twice per year
  • PML, Progressive multifocal leukoencephalopathy.